Press Release: TwoXAR : twoXAR Pharmaceuticals Presents Preclinical Data Demonstrating Positive Safety and Tolerability of Two Novel NASH Treatment Candidates

PALO ALTO, Calif., Nov. 13, 2020 /PRNewswire/ -- twoXAR Pharmaceuticals, a drug discovery and development company focused on bringing first-in-class small molecules to market, today announced that two novel leads for the potential treatment of non-alcoholic steatohepatitis (NASH), TXR-611...